Ocular Therapeutix announces first patient dosed in phase 1 clinical trial of OTX-CSI to treat dry eye disease

Ocular Therapeutix has announced that first patient has been dosed in phase 1 clinical trial of OTX-CSI to treat dry eye disease. (Credit: Daniel Roberts from Pixabay)